US Trial Testing Mylotarg Plus Venclexta for AML Now Enrolling Participants
News
A Phase 1b study testing Mylotarg (gemtuzumab ozogamicin) plus Venclexta (venetoclax) for adults with relapsing or refractory acute myeloid leukemia (AML) is currently enrolling patients. The trial (NCT04070768) is taking place across four clinical sites ... Read more